Next Gen Diagnostics Expands U.S. Operations with New Lab in Kendall Square

Move positions Company at the heart of Cambridge’s innovation ecosystem to accelerate growth and collaboration in infection prevention

[PRNewswire] Next Gen Diagnostics, a biotechnology company delivering automated whole genome sequencing and bioinformatics to track infection transmission in real time, today announced the relocation of its laboratory to Kendall Square in Cambridge, Massachusetts.

Press Release
Next
Next

Drs. Lee Harrison and Alex Sundermann Join Next Gen Diagnostics Advisory Team to Advance Hospital-Based Infection Prevention